Utilization and metabolism of NAD by Haemophilus parainfluenzae
- PMID: 3254936
- DOI: 10.1099/00221287-134-10-2789
Utilization and metabolism of NAD by Haemophilus parainfluenzae
Abstract
The utilization of exogenous nicotinamide adenine dinucleotide (NAD) by Haemophilus parainfluenzae was studied in suspensions of whole cells using radiolabelled NAD, nicotinamide mononucleotide (NMN), and nicotinamide ribonucleoside (NR). The utilization of these compounds by H. parainfluenzae has the following characteristics. (1) NAD is not taken up intact, but rather is degraded to NMN or NR prior to internalization. (2) Uptake is carrier-mediated and energy-dependent with saturation kinetics. (3) There is specificity for the beta-configuration of the glycopyridine linkage. (4) An intact carboxamide groups is required on the pyridine ring. The intracellular metabolism of NAD was studied in crude cell extracts and in whole cells using carbonyl-14C-labelled NR, NMN, NAD, nicotinamide, and nicotinic acid as substrates in separate experiments. A synthetic pathway from NR through NMN to NAD that requires Mg2+ and ATP was demonstrated. Nicotinamide was found as an end-product of NAD degradation. Nicotinic acid mononucleotide and nicotinic acid adenine dinucleotide were not found as intermediates. The NAD synthetic pathway in H. parainfluenzae differs from the Preiss-Handler pathway and the pyridine nucleotide cycles described in other bacteria.
Similar articles
-
Pyridine nucleotide metabolism by extracts derived from Haemophilus parasuis and H. pleuropneumoniae.Can J Microbiol. 1986 Sep;32(9):733-7. doi: 10.1139/m86-133. Can J Microbiol. 1986. PMID: 2946387
-
Nucleoside salvage pathway for NAD biosynthesis in Salmonella typhimurium.J Bacteriol. 1982 Dec;152(3):1111-6. doi: 10.1128/jb.152.3.1111-1116.1982. J Bacteriol. 1982. PMID: 6216244 Free PMC article.
-
Pyridine nucleotide cycle of Salmonella typhimurium: in vitro demonstration of nicotinamide adenine dinucleotide glycohydrolase, nicotinamide mononucleotide glycohydrolase, and nicotinamide adenine dinucleotide pyrophosphatase activities.J Bacteriol. 1981 Feb;145(2):1002-9. doi: 10.1128/jb.145.2.1002-1009.1981. J Bacteriol. 1981. PMID: 6109709 Free PMC article.
-
A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction.J Drugs Dermatol. 2022 Oct 1;21(10):1129-1132. doi: 10.36849/JDD.6870. J Drugs Dermatol. 2022. PMID: 36219044 Review.
-
Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Novel approaches for better aging.Aging Med (Milton). 2021 Aug 4;4(3):214-220. doi: 10.1002/agm2.12170. eCollection 2021 Sep. Aging Med (Milton). 2021. PMID: 34553119 Free PMC article. Review.
Cited by
-
From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways.J Bacteriol. 2002 Aug;184(16):4555-72. doi: 10.1128/JB.184.16.4555-4572.2002. J Bacteriol. 2002. PMID: 12142426 Free PMC article.
-
Vibrio Phage KVP40 Encodes a Functional NAD+ Salvage Pathway.J Bacteriol. 2017 Apr 11;199(9):e00855-16. doi: 10.1128/JB.00855-16. Print 2017 May 1. J Bacteriol. 2017. PMID: 28167526 Free PMC article.
-
In vitro evaluation of nicotinamide riboside analogs against Haemophilus influenzae.Antimicrob Agents Chemother. 1990 Aug;34(8):1473-9. doi: 10.1128/AAC.34.8.1473. Antimicrob Agents Chemother. 1990. PMID: 2145800 Free PMC article.
-
Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence.J Bacteriol. 2001 Feb;183(4):1168-74. doi: 10.1128/JB.183.4.1168-1174.2001. J Bacteriol. 2001. PMID: 11157928 Free PMC article.
-
The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.Am J Physiol Cell Physiol. 2022 Mar 1;322(3):C521-C545. doi: 10.1152/ajpcell.00451.2021. Epub 2022 Feb 9. Am J Physiol Cell Physiol. 2022. PMID: 35138178 Free PMC article. Review.